Physician
Pomykala, Matthew
Pomykala, Matthew was paid $1.05M by Medicaid between Jan 2018 and Dec 2024, across 11 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 53% of everything it billed.
33Billing provider infoPOMYKALA, MATTHEW
MIDDLETOWN, NY 10941
MIDDLETOWN, NY 10941
33aNPI1548578594assigned 09/23/2010
33bProvider typeOphthalmology Physician
28Total paid$1.05M
24GClaims11,714
24DCodes billed11
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in New York
Rank by total paid#104 of 1,085
Median peer was paid$34K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 730 | $19K | |
| 2019 | 1,450 | $66K | |
| 2020 | 1,776 | $168K | |
| 2021 | 2,479 | $266K | |
| 2022 | 2,468 | $320K | |
| 2023 | 1,602 | $128K | |
| 2024incomplete | 1,209 | $81K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 53% | 847 | 739 | $554K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 17% | 2,992 | 2,959 | $179K |
| 67028 | Intravitreal injection of a pharmacologic agent | 9.7% | 2,019 | 1,709 | $102K |
| 92134 | 6.7% | 3,467 | 3,411 | $71K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 4.8% | 468 | 468 | $51K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.8% | 853 | 841 | $40K |
| 92235 | 3.6% | 571 | 567 | $38K | |
| J9035 | Injection, bevacizumab, 10 mg | 1.2% | 364 | 305 | $13K |
| 92250 | <1% | 42 | 42 | $1K | |
| 92201 | <1% | 79 | 70 | $801.29 | |
| 92227 | <1% | 12 | 12 | $244.08 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.